SPECIAL TOPICS

Diabetes - May 2009

Interview Menu

Read interviews, first-person essays, profiles, and other features about people in a wide variety of fields, along with information on journals & institutions in the topic of Diabetes. All of the author comments below are also listed in the site-wide Author Commentaries listings (available by month/year or alphabetically).

	September 2009 Philip Raskin; According to the Special Topics Research Front Map on Insulin Treatment of Type 2 Diabetes, the paper "Initiating insulin therapy in type 2 diabetes—a comparison of biphasic and basal insulin analogs" (Raskin P, et al., Diabetes Care 28[2]: 260-5, February 2005) is a key paper, with 178 cites to its credit. In this interview, ScienceWatch.com's Jennifer Minnick talks with lead author Dr. Philip Raskin about this paper and its impact on the field. View Article
	August 2009 Mark Cooper; In our Special Topics analysis of diabetes research over the past decade, the work of Dr. Mark Cooper ranks at #6 by total cites, based on 130 papers cited a total of 6,085 times. According to Essential Science IndicatorsSM from Thomson Reuters, Dr. Cooper's record includes 246 papers, the majority of which are classified under Clinical Medicine, cited a total of 7,787 times. ScienceWatch.com correspondent Gary Taubes talks with Dr. Cooper about his highly cited work in this field. View Article
	July 2009 David Nathan; In our Special Topics analysis on diabetes research over the past decade, the work of Dr. David Nathan ranks at #7 by total cites, and #1 by cites/paper, based on 72 papers cited a total of 6,040 times. According to Essential Science IndicatorsSM from Thomson Reuters, his record includes 102 papers, cited a total of 8,333 times. In this interview, Dr. Nathan, talks with ScienceWatch.com correspondent Gary Taubes about his highly cited work. View Article
	June 2009 JoAnn Manson; According to our 2009 Special Topics analysis of diabetes research, the work of Dr. JoAnn E. Manson ranks at #8 by total cites, based on 102 papers cited a total of 6,033 times. In Essential Science IndicatorsSM from Thomson Reuters, Dr. Manson is in the top 1% of authors in the field of Clinical Medicine. In this interview, she talks with ScienceWatch.com about her highly cited work in diabetes. View Article
	June 2009 Bo Ahrén; In our Special Topics analysis of diabetes research over the past decade, the paper "Inhibition of dipeptidyl peptidase IV improves metabolic control over a 4 week study period in type 2 diabetes," (Ahrén B, et al., Diabetes Care 25:869-875 [2002]) is the #1 paper in the Research Front Map Dipeptidyl Peptidase-4 Inhibition Treatment of Type 2 Diabetes. Lead author Dr. Bo Ahrén is the Dean of the Faculty of Medicine at Lund University in Sweden, and in this interview, he talks with ScienceWatch.com about this paper and its impact on the research community. View Article